Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
13 reviews, newest first
Methotrexate for juvenile idiopathic arthritis
Cochraneheadline outcomes only
24 findings
Methotrexate for psoriatic arthritis
Cochraneheadline outcomes only
16 findings
Methotrexate for maintenance of remission in ulcerative colitis
Cochraneheadline outcomes only
4 findings
Methotrexate for treating rheumatoid arthritis
Cochraneheadline outcomes only
7 findings
Methotrexate for induction of remission in refractory Crohn's disease
Cochraneheadline outcomes only
20 findings
Methotrexate for induction of remission in ulcerative colitis
Cochraneheadline outcomes only
3 findings
Methotrexate for maintenance of remission in Crohn's disease
Cochraneheadline outcomes only
5 findings
Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation
Cochraneheadline outcomes only
8 findings
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
Cochraneheadline outcomes only
21 findings
Methotrexate for ankylosing spondylitis
Cochraneheadline outcomes only
7 findings
Role of chemotherapy additional to high‐dose methotrexate for primary central nervous system lymphoma (PCNSL)
Cochraneheadline outcomes only
5 findings
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
Cochraneheadline outcomes only
6 findings
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
Cochraneheadline outcomes only
7 findings